Germline testing
Germline testing has been studied in 2 papers since 2026: 1 observational study in people, 1 review; 2 in the past year. The newest paper, Nov 10, 2026: “Precision Oncology for Pancreatic Ductal Adenocarcinoma: Germline Mutations and High-Risk Surveillance”.
2 papers study it1 findingUpdated
1 new paper in 30 daysSee all 2 papers on germline testing
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Overall, forty-four (8.8%) out of 500 HRI-FHs carried at least one PGV”
- 1 lab in 1 country
- Funder: Fondazione Nadia Valsecchi
- 1 of 1 finding with company ties
- Humans1
What is germline testing linked with?
1Studies link germline testing with pathogenic/likely pathogenic variant carriage.
Pathogenic/likely pathogenic variant carriage
upin humans1
1 study
Pathogenic/likely pathogenic variant carriage
upin humans1
Germline testing is associated with pathogenic/likely pathogenic variant carriage in humans (high-risk individuals due to familial pancreatic cancer) (44/500 (8.8%) carried at least one PGV).
“Overall, forty-four (8.8%) out of 500 HRI-FHs carried at least one PGV”
Humanshigh-risk individuals due to familial pancreatic cancern = 500
United European gastroenterology journal